Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

12 results
  1. NLM Digital Collections - British guideline on the management of asthma : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), September 2016
    ... 9.8.6 LEUKOTRIENE RECEPTOR ANTAGONISTS Initiating oral montelukast in primary care settings, early after the onset ... exposed 4 to LTRAs (two in women taking montelukast) showed no increased risk of congenital malformations.837- ...
  2. NLM Digital Collections - British guideline on the management of asthma : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), July 2019
    ... 9.8.6 Leukotriene receptor antagonists Initiating oral montelukast in primary care settings, early after the onset ... women exposed to LTRAs (two in women taking montelukast) showed no increased risk of congenital malformations.848- ...
  3. NLM Digital Collections - British guideline on the management of asthma : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), October 2014
    ... 8.8.5 LEUKOTRIENE RECEPTOR ANTAGONISTS Initiating oral montelukast in primary care settings, early after the onset ... women exposed to LTRAs (two in women taking montelukast) showed no increased risk of congenital malformations.788- ...
  4. ... years of age. 6.5.3leukotriene receptor antagonist (montelukast) Only one study on the use of montelukast in children with bronchiolitis was identified. For children ...
  5. NLM Digital Collections - Children's health spending : 2010-2013 
    Publication: Washington, DC, : Health Care Cost Institute, July 2015
    ... the patent expiration of the leukotriene modifier Singulair® (montelukast sodium) in 2012, an asthma and allergy treatment ... Administration (FDA) approved the first generic versions of montelukast sodium for use in chil- dren to control ...
  6. NLM Digital Collections - Biologic therapies for treatment of asthma associated with type 2 inflammation : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2018
    ... Treatment of Asthma iv. Leukotriene modifiers include LTRAs (montelukast and zafirlukast) and a 5- lipoxygenase inhibitor (zileuton). ... in adults with moderate to severe asthma. However, montelukast has been shown to be less effective than ...
  7. NLM Digital Collections - Part D plans generally include drugs commonly used by dual eligibles : 2018 
    Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
    ... 4,383,617–6,471,253 372 96% Montelukast Sodium 1,145 5,240,144 3,928, ...
  8. ... Opioid Analgesics, Oral $2.14 -16.0% 11 montelukast sodium 10 mg tablet 90 Teva Pharmaceuticals Respiratory ...
  9. NLM Digital Collections - Medicaid's most costly outpatient drugs 
    Publication: Menlo Park, CA : Henry J. Kaiser Family Foundation, July 2016
    ... Sodium Thyroid Agents 11 Cetirizine HCl Antihistamines 12 Montelukast Sodium Antiasthmatic and Bronchodilator Agents 13 ProAir HFA ...
  10. NLM Digital Collections - Part D plans generally include drugs commonly used by dual eligibles : 2019 
    Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2019
    ... 3,787,931 7,609,444 293 73% Montelukast Sodium 829 5,647,132 4,233,914 ...
previous · 1 · 2 · next